eremanthin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daisy, P; Duraipandiyan, V; Eliza, J; Ignacimuthu, S | 1 |
| Daisy, P; Eliza, J; Ignacimuthu, S | 1 |
2 other study(ies) available for eremanthin and Alloxan Diabetes
| Article | Year |
|---|---|
Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats.
Topics: Acid Phosphatase; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Glucose; Blood Proteins; Cholesterol; Costus; Diabetes Mellitus, Experimental; Gas Chromatography-Mass Spectrometry; Glycated Hemoglobin; Glycogen; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; L-Lactate Dehydrogenase; Male; Rats; Rats, Wistar; Sesquiterpenes; Triglycerides | 2009 |
Antioxidant activity of costunolide and eremanthin isolated from Costus speciosus (Koen ex. Retz) Sm.
Topics: Animals; Antioxidants; Blood Glucose; Costus; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glutathione; Male; Oxidative Stress; Rats; Rats, Wistar; Sesquiterpenes; Thiobarbituric Acid Reactive Substances; Toxicity Tests, Acute | 2010 |